Lawrence Livermore National Laboratory and Loyola University won a $3.5 million grant from the National Institutes of Health to develop a new anthrax vaccine.
This is the first grant from the NIH that focuses on a particular type of vaccine using nanolipoprotein, or NLP, technology developed at the lab.
No comments:
Post a Comment